These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 6157614)
1. Disturbances of desmofibrinogenesis in pateints suffering from acute myeloblastic leukemia. Kłoczko J; Zuch A; Bielawiec M Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):125-30. PubMed ID: 6157614 [TBL] [Abstract][Full Text] [Related]
2. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography]. Anders O; Görss EW; Ernst B; Konrad H Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208 [TBL] [Abstract][Full Text] [Related]
3. Fibrinogen survival with 75-seleniomethionine in acute myeloblastic leukemia during polychemotherapy. Barbui T; Battista R; Dini E Haematologica; 1976 Mar; 61(1):73-80. PubMed ID: 820599 [No Abstract] [Full Text] [Related]
4. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [TBL] [Abstract][Full Text] [Related]
5. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Lu C; Hassan HT Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of acute myeloblastic leukemia in patients over 60. Apropos of 22 cases]. Bernard JF; Garbaz M; Kahn A; Hakim J; Amar M; Boivin P Nouv Presse Med; 1974 Jun; 3(26):1653-6. PubMed ID: 4526607 [No Abstract] [Full Text] [Related]
7. [Clinical usefulness of determination of the sensitivity of myeloblastic leukemia cells to antiproliferative drugs in cell culture in vivo]. Hansz J; Pytlak B; Drozdowska D Acta Haematol Pol; 1981; 12(1):1-6. PubMed ID: 6947679 [TBL] [Abstract][Full Text] [Related]
8. [Cytosine arabinoside alone and in association to other drugs in the therapy of acute myeloblastic leukemia]. Tura S; Ricci P; Baccarani M; Lauria F; Santucci MA Haematologica; 1972; 57(7):359-70. PubMed ID: 4628583 [No Abstract] [Full Text] [Related]
9. [Experiences in the induction of remission and in maintenance therapy in acute myeloblastic leukemia in adults with the RAMPO scheme]. Höche D; Herold M; Fink R; Anger G Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):237-43. PubMed ID: 6168533 [No Abstract] [Full Text] [Related]
10. [Activity of the fibrin-stabilizing factor in acute leukemia]. Tentsova IA Probl Gematol Pereliv Krovi; 1974; 19(5):33-6. PubMed ID: 4524610 [No Abstract] [Full Text] [Related]
11. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients. Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute leukemias]. Gross R; Gerecke D Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072 [TBL] [Abstract][Full Text] [Related]
13. Androgen therapy during myeloblastic leukemia remission induced by two drug combinations. Pavlovsky S; Scaglione C; Eppinger-Helft M; Muriel FS; Macchi A; Garay G; Cavagnaro F; Birman V; Dupont J; Suarez A; Dragosky MO; Barros CA Medicina (B Aires); 1981; 41(1):11-8. PubMed ID: 7022104 [No Abstract] [Full Text] [Related]
14. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Siebenlist KR; Meh DA; Mosesson MW Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711 [TBL] [Abstract][Full Text] [Related]
15. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia. Masaoka T; Ogawa M; Yamada K; Kimura K; Ohashi Y Semin Hematol; 1996 Oct; 33(4 Suppl 3):12-7. PubMed ID: 8916311 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of acute myeloblastic leukemia by rubidomycin. Statistics on 35 cases]. Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B Lille Med; 1969 Mar; 14(3):257-63. PubMed ID: 5261958 [No Abstract] [Full Text] [Related]
17. Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia. Löfgren C; Lehmann S; Jönsson-Videsäter K; Möllgård L; Linder O; Tidefelt U; Hassan M; Paul C Ther Drug Monit; 2007 Oct; 29(5):626-31. PubMed ID: 17898654 [TBL] [Abstract][Full Text] [Related]
18. [Effect of hormonal contraception on the fibrin-stabilizing factor (factor XIII)]. Brandt M; Hofmann KD; Wagner F; Koob P Zentralbl Gynakol; 1978; 100(17):1089-92. PubMed ID: 716679 [TBL] [Abstract][Full Text] [Related]
19. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells. Gustavsson A; Olofsson T Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116 [TBL] [Abstract][Full Text] [Related]